Bioelectric Medicine Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry.”

“Bioelectric Medicine Market” research report offers the breakdown of the industry by market size, rate of development, key companies, counties, product selections and application. The Bioelectric Medicine Market Report delivers current state, openings, limits, drivers and also the evolution forecasts of the market by 2025. Profound investigation about Bioelectric Medicine market standing, enterprise competition outline, welfares and drawbacks of enterprise stock, Bioelectric Medicine industry development trends, regional industrial layout features and economics policies, industry News and Strategies by Regions has additionally been enclosed.

Get a Sample Copy of the Report at- https://www.industryresearch.co/enquiry/request-sample/16705148

In Regional Analysis, the Bioelectric Medicine market is also categorised into North America, Europe, China, Japan, the middle East, India, South America, Others. North America, Europe is expected to account for a distinguished share, in terms of price and extent, of the Bioelectric Medicine market throughout the forecast length. The Bioelectric Medicine market within the Asia Pacific is projected to extend throughout the forecast period. Evolving markets that include China and Asian country are expected to play a significant position within the boom in producing the surrounding area.

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

To Understand the Impact of COVID-19 on Bioelectric Medicine Market: – https://www.industryresearch.co/enquiry/request-covid19/16705148

Bioelectric Medicine market report provides in-depth data about company Profiles, Bioelectric Medicine launching and Market Positioning, their Production, Value, Price, ratio and Target Customers. Research report contains data about following major players in Bioelectric Medicine market, which strategically profile the key players and comprehensively analyse their growth strategies and market segmentation:

Key players in the global Bioelectric Medicine market covered in report:

● Nevro ● Second Sight Medical Products ● Sonova Holding ● St. Jude Medical ● Medtronic ● Cochlear ● Electrocore ● Boston Scientific Corporation ● Livanova ● Biotronik

On the basis of types, the Bioelectric Medicine market from 2015 to 2025 is primarily split into:

● Implantable Cardioverter Defibrillators ● Cardiac Pacemakers ● Spinal Cord Stimulators ● Cochlear Implants ● Deep Brain Stimulators ● Transcutaneous Electrical Nerve Stimulators ● Vagus Nerve Stimulators ● Sacral Nerve Stimulators ● Retinal Implants ● Other Electrical Stimulators

On the basis of applications, the Bioelectric Medicine market from 2015 to 2025 covers:

● Hospitals ● Research Institutes ● Individual Users

Inquire or Share Your Questions If Any Before the Purchasing This Report- https://www.industryresearch.co/enquiry/pre-order-enquiry/16705148

Bioelectric Medicine Market Report Scope:

The In-depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis. This Bioelectric Medicine Market report describes present situation, historical background and future forecast. It Comprehensive data showing Bioelectric Medicine sale, consumption, trade statistics, and prices in the recent years are provided. The Bioelectric Medicine report indicates a wealth of information on Bioelectric Medicine vendors. Bioelectric Medicine Market forecast for next five years, including Market volumes

Read more

Nova Scotia fitness business requests exemption to stay open amid COVID-19

The owner of a fitness facility in Halifax has written a letter to the province asking for an exemption to stay open out of concern for his clients.



a desktop computer sitting on top of a chair: Image of OneUp Fitness.


© Global/Ashley Fields
Image of OneUp Fitness.

The owner of OneUp Fitness, Matt Mombourquette, said what sets his facility apart from other commercial gyms is its small size, one-on-one, appointment based-training. Its average demographic is people aged 55 and up.

“A lot of our clients have chronic health conditions, such as osteoporosis, orthopedic pain, we have some clients with Parkinson’s disease, muscular dystrophy,” said Mombourquette.

So when the province announced a second round of lockdown for fitness facilities, Mombourquette said he was concerned for his aging clientele.

Read more: Nova Scotia reports 37 new cases of COVID-19, shuts down bars, gyms

Between the facility’s Halifax and Bedford studios, Mombourquette said, they see roughly 150 clients per week, but fewer than half took up virtual classes when their doors closed in March.

“When they came back and we opened our doors again in June, we could see a lot of deterioration. They shared that they had a lot of physical challenges; they felt weaker, and some of them had some depression,” he said.

This is when he decided to write the letter to see if there was “some wiggle room” that existed for their facility.

On Tuesday, Dr. Robert Strang, chief medial officer of Nova Scotia, said there will be no exceptions to the rule.

“Our goal is to remain very tight for the shortest time possible, and every time we give an exception it creates another opportunity for a breakthrough that might then be the reason why we have to extend,” Strang said.

Trail use has increased during the coronavirus pandemic

UP NEXT

UP NEXT

It’s a decision Mombourquette respects but says he’s frustrated by.

“I think everybody understands that exercise does have a big impact on positive immunity and keeping us safe from this current pandemic and potentially future ones,” he said.

One of Mombourquette’s clients is Jason Roth, a 70-year-old Halifax man, who has been coming to OneUp Fitness twice a week for the past 15 years. He tells Global News his health took a hit when the facility’s doors closed in March due to COVID-19.

“In terms of the sense of being in shape and fitness, I would say was about 50 per cent as effective as it had been,” said Roth.

He says he’s been to other, larger gyms and OneUp Fitness is different. He doesn’t believe it should be lumped into the same category.

“I’m not surrounded by a lot of people, equipment is immediately wiped down, people are in and people are out,” he said.

“That distinction between eating establishments and drive thru establishments, I think, would fit as a distinction between OneUp and the average gym.”

Fitness centre owner hoping to stay open amid COVID-19 closures

UP NEXT

UP NEXT

Roth said that if an exemption were to be granted, he would gladly

Read more

R.I. fitness clubs fined for refusing to close during two-week COVID-19 ‘pause’

WARREN, R.I. — An owner of fitness clubs in Rhode Island is defying an order from Governor Gina M. Raimondo for all gyms and recreational facilities to close for two weeks as health officials try to slow an alarming spike in COVID-19 cases.



a man holding a phone: The owner of Maxx Fitness Clubzz, Matt D'Amico, leaves his facility in Lincoln on Wednesday. He has decided to stay open despite the governor's orders for fitness clubs to close for two week. He said the spring closure was financially devastating.


© John Tlumacki/Globe Staff
The owner of Maxx Fitness Clubzz, Matt D’Amico, leaves his facility in Lincoln on Wednesday. He has decided to stay open despite the governor’s orders for fitness clubs to close for two week. He said the spring closure was financially devastating.

The two-week pause that started Monday closed bars, gyms, and casinos, asks most high school students to learn from home, and orders companies to have most employees work from home.

Matt D’Amico, who owns The Maxx Fitness Clubzz franchises in Lincoln and Warren, opened as usual on Monday, however, and has remained open since then. He said that closing would be financially devastating.

Loading...

Load Error

“We did it in March and the shutdown lasted 10, 12 weeks. I just can’t survive it again,” D’Amico said. “It’s not about profitability — it’s landlords, equipment rentals, payroll and staff. And, I don’t think it’s right, when everyone else gets to stay open.”

The Health Department issued $500 fines at both locations and ordered the facilities to close immediately and stay closed until the restrictions are lifted.

But D’Amico has refused to shut down. Both Maxx locations were open and busy Wednesday.

“You can say we’re fighting for freedom. It’s what it is,” D’Amico said. “I invested millions of dollars.”

Raimondo ordered the two-week pause in an attempt to stem the rising wave of new COVID-19 cases and hospitalizations, which led to the opening of field hospitals on Monday. Rhode Island was up to 59,005 confirmed coronavirus cases on Wednesday, with 1,032 new cases, 11 more deaths, and 408 people hospitalized.

The governor’s office and Health Department referred questions about Maxx Fitness Clubzz to the state Department of Business Regulation, where a spokesman declined to comment “as it is an ongoing and actively evolving situation.”

The fitness clubs are the first businesses to be cited since the pause began on Monday. “I have legal counsel, and we’ll take it day by day,” D’Amico said. “I don’t think fitness centers should be singled out… I believe I have constitutional rights to be able to operate my business.”

D’Amico said his fitness centers have complied with other coronavirus-related all of the Health regulations, keeping the facilities clean and screening staff and customers for COVID-19 symptoms. Health officials told them that some visitors to the fitness centers had tested positive for COVID, but they inspected the facilities and found no problems, he said.

“We have a bunch of customers, and a lot of new members are signing up,” Stephen Couture, the manager of the Lincoln club, said Wednesday.

Read more

Personalized Medicine Market 2020 Research Report by Size, Revenue, Opportunities, COVID-19 Impact, Status and Outlook to 2024 | Absolute Reports

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Global “Personalized Medicine Market” forecast 2020-2024 is a historical overview and in-depth study on the present and upcoming market of the Personalized Medicine industry. The report represents a basic overview of the Personalized Medicine market size, share, and competitor segment with a basic introduction of manufactures, geographical regions, product types, and applications. This report gives a historical overview of the Personalized Medicine market trends, growth, revenue, capacity, cost structure, and key driver’s analysis.

About Personalized Medicine:

Individualized medication, medication “vary from person to person” , give full consideration to each patient’s genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

Get a Sample Copy of the Report – https://www.absolutereports.com/enquiry/request-sample/14684359

Personalized Medicine Market Segment by Manufacturers, this report covers:

● Abbott Laboratories ● Agilent Technologies ● Amgen ● Astellas Pharma ● Astrazeneca ● Bayer AG ● Celgene Corporation ● Glaxosmithkline Plc ● Illumina ● Johnson and Johnson ● Laboratory Corporation ● Merck ● Novartis AG ● Roche Holding AG ● Siemens AG ● Takeda Pharmaceutical Company Limited

Market Segment by Regions, regional analysis covers:

● North America (United States, Canada and Mexico) ● Europe (Germany, France, UK, Russia and Italy) ● Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ● South America (Brazil, Argentina, Colombia etc.) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers:

● Personalized Medicine Diagnostics ● Personalized Medical Care ● Personalized Medicine Therapeutics ● Personalized Nutrition and Wellness

Market Segment by Applications, can be divided into:

● Oncology ● Central Nervous System (CNS) ● Immunology ● Respiratory ● Other Applications ● Personalized MedicinePersonalized Medicine

To Understand How Covid-19 Impact Is Covered in This Report – https://www.absolutereports.com/enquiry/request-covid19/14684359

Scope of this report:

● The global Personalized Medicine market is expected to reach significant USD by the end of 2024. ● The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. ● North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Personalized Medicine. ● Europe also play important roles in global market, with market size of significant USD in 2019. ● This report studies the Personalized Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Personalized Medicine market by product type and applications/end industries.

The content of the study subjects includes a total of 15 chapters:

● Chapter 1, to describe Personalized Medicine product scope, market overview, market opportunities, market driving force and market

Read more

Clinical trials are key to advancing medicine, including COVID-19 vaccine

MIAMI – Registered clinical trials reached record levels in the past year, increasing the demand for people willing to participate, and Miami resident Marilyn Strauss Diaz was eager to join a COVID-19 vaccine trial underway at the University of Miami Health System.

“We can’t depend on a lab rat. We have to have human trials for there to be a successful vaccine, so we have to have humans come forward and be a part of trials,” she said.

“Before COVID, we usually would have a couple of hundred clinical trials here going at the same time at the University of Miami that are focused on a lot of different diseases. With COVID, there was a slowdown and now we’re ramping up again and starting a lot of these studies,” said Dr. Olveen Carassquillo, who is part of the research team.

“COVID has the most urgency. That’s a public health crisis so a lot of research is focused on that, but we have a lot of landmark cancer studies going on with different treatment regimens and prevention studies. We also have a lot of cardiovascular disease, a lot of other studies focused on stroke, on preventing dementia,” Carassquillo added.

And South Florida’s diverse population makes it a major focus of research efforts, something Strauss Diaz is proud to be a part of.

“At the end, it will be beneficial to so many,” she said.

To learn more about clinical trials at the University of Miami Health System go to: https://umiamihealth.org/clinical-trials

Copyright 2020 by WPLG Local10.com – All rights reserved.

Source Article

Read more

Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – Press Release

New York, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05993422/?utm_source=GNW

The Global Nuclear Medicine Market is expected to grow from USD 3,812.67 Million in 2019 to USD 5,701.38 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.93%.

Market Segmentation & Coverage:
This research report categorizes the Nuclear Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Nuclear Medicine Market studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products further studied across PET and SPECT. The Therapeutic Products further studied across Alpha Emitters, Beta Emitters, and Brachytherapy.

Based on Application, the Nuclear Medicine Market studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid.

Based on Geography, the Nuclear Medicine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Nuclear Medicine Market including Australian Nuclear Science & Technology Organization (ANSTO), Bracco Imaging S.p.A, Curium Pharma, Eckert & Ziegler, Eczacibasi-Monrol, GE Healthcare, Jubilant Pharma. LLC, Lantheus Medical Imaging, Inc., Mallinckrodt, Nordion (Canada) Inc., NTP Radioisotopes SOC Ltd., and The Institute for Radioelements (IRE – IRE ELiT).

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nuclear Medicine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces,

Read more

How digital healthcare tools are changing medicine in Europe since COVID-19

Like in America, the healthcare industry is also making shifts to adopt new, safer hospital practices in response to Covid-19. Since physical contact and proximity present such risks, hospitals are turning to a variety of digital tools in order to meet their care priorities, such as risk reduction and better resource utilization. Having a better understanding of these priorities and what tools hospitals are using now will help us in the health tech industry know what to build for them next.

At Siilo, we believe that putting tried and true technology into the hands of healthcare professionals will result in a higher quality of care for patients down the line. Here are the three major categories of care currently being aided by digital tools: distance diagnoses, internal communications, and external collaborations.

Distance diagnoses
Covid-19 was not the start of the telehealth revolution, but it was certainly a major driver in its widespread adoption this year. While doctors and specialists could not and still cannot see their patients in person, that doesn’t mean people haven’t stopped needing consultations. Moving diagnoses online has been the only option to continue delivering care directly to patients.

Companies like Germany’s Klara are working to put these digital tools at the center of doctor-patient communication all across Europe. Telehealth services provide a variety of benefits: anything from patient portals, where individuals can email their doctors in a secure online environment, to mobile applications, allowing doctors to hold virtual appointments with patients via video call. They can also include the collection of health data, voluntarily given by patients, through the Internet of Things, such as smartwatches, in order to get a more holistic view of the patient’s wellbeing.

Advances in telehealth can certainly ease the burdens on healthcare professionals looking to safely diagnose their patients over digital platforms, but we need to make sure that we are providing products that prioritize data safety. That means designing for GDPR compliance incorporating key features, like passcode protection and device-only data storage.

Internal Communications
The influx of telehealth and digital solutions for communicating with patients has also resulted in a professional counterpart for members of medical institutions, organizations, and associations all across Europe. Beyond the EHRs and secure email servers typically found in hospitals or physicians’ offices, technology is being developed to make communication by modern healthcare professionals more efficient, more secure, and more informative.

People bring their smartphones to work with them, and as such, we see professionals increasingly seeking out mobile tools and applications to simplify their workflows. In particular, professionals are looking for ways to quickly exchange information with each other and their departments at large. My company, Siilo works in this space.

This integration is not seamless, however. Bring-your-own-device policies, such as those found in Germany and France, have been put in place to limit the chances of cross-contaminating patient data and personal information, and increasing digital literacy amongst professionals can be a difficult and time-consuming endeavor. Nevertheless, hospitals and public health institutions should be prepared

Read more

Regenerative Medicine Market Futuristic Comprehensive Insights with COVID-19 Impact Analysis | Organogenesis Inc, Osiris Therapeutics Inc

The MarketWatch News Department was not involved in the creation of this content.

Nov 29, 2020 (MarketResearch.biz via Comtex) —
A consciously conceived and designed business intelligence report titled Global Regenerative Medicine market 2020 by Manufacturers, Type, and Application, Forecast to 2029 by MarketResearch.biz discloses a succinct analysis of the regional spectrum, market size, and revenue forecast about the market. This report sheds light on the vital developments along with other events happening in the global Regenerative Medicine market which is marking on the enlargement and opening doors for outlook growth in the coming years.

This is the latest report, covering the current COVID-19/Corona Virus pandemic impact on the market which has affected every aspect of life globally. This has brought along several changes in market conditions and the Business areas. The rapidly changing market scenario and initial and future assessment of the impact are covered in the Regenerative Medicine market report. 

For All-Inclusive Information: Download a FREE sample copy of Regenerative Medicine Market Report Study 2020-2029 at https://marketresearch.biz/report/regenerative-medicine-market/request-sample

(Our FREE SAMPLE COPY of the report gives a brief introduction to the research report outlook, list of tables and figures, Impact Analysis of COVID-19, TOC, an outlook to key players of the market and comprising key regions.)

Competitive Analysis:

The major companies are exceedingly focused on innovation in Regenerative Medicine production technology to enhance ledge life and efficiency. The best long-term development path for Regenerative Medicine market can be caught by guaranteeing financial pliancy to invest in the optimal strategies and current process improvement.

Key manufacturers are included based on the company profile, sales data and product specifications, etc: Organogenesis Inc, Osiris Therapeutics Inc, Pfizer Inc, Novartis AG, Vericel Corporation, NuVasive Inc, Cook Biotech Inc, GlaxoSmithKline plc., Boehringer Ingelheim GmbH, Amgen Inc

Each manufacturer or Regenerative Medicine market player’s growth rate, gross profit margin, and revenue figures is provided in a tabular, simple format for few years and an individual section on Regenerative Medicine market recent development such as collaboration, mergers, acquisition, and any new service or new product launching in the market is offered.

Regenerative Medicine Market Segmentation Outlook By therapy, product type, application, and region:

By therapy: Cell Therapy Tissue Engineering Immunotherapy Gene Therapy By product type: Cell-Based Products Allogeneic Products Autologous Products Acellular Products By application: Orthopedic & Musculoskeletal Disorders Dermatology Cardiology Dermatology Diabetes Central Nervous System Disorders Others

Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Regenerative Medicine Market: https://marketresearch.biz/report/regenerative-medicine-market/covid-19-impact

Regional Analysis:On the idea of geography, the Regenerative Medicine Market report covers statistics for a couple of geographies inclusive of, North America (U.S., Mexico, Canada) South America (Argentina, Brazil) The Middle East & Africa (South Africa, Saudi Arabia) Asia-Pacific (China, Japan, India, Southeast Asia) Europe (U.K., Spain, Italy, Germany, France, Russia)

In addition, The following years considered for this study to forecast the global Regenerative Medicine market size are as follows:

– Actual Year: 2019

– Estimated Year: 2020

– Forecast Year: 2020–2029

Some Fundamental Report Highlights:

– Thorough Outline

Read more

Alberta fitness studios confused by COVID-19 restrictions on group classes, workouts

The Alberta government’s recent COVID-19 restrictions are impacting smaller fitness studios and many owners admit is a bit confusing.



Orange Theory Fitness ensures sanitization of all equipment.


© Jill Croteau/Global News
Orange Theory Fitness ensures sanitization of all equipment.

According to new health guidelines announced Tuesday, gyms all group classes aren’t allowed. Fitness studios, like Revive Lifestyle Fitness, can’t  do group training or semi-private training.  Owner Mike Du said they are only allowed to conduct one on ones, if a coach is involved.

Read more: The New Reality: The uncertain future of fitness studios

He says the problem is gyms can still have a group of members working out together, physically distanced. The trainer has to be kept outside the room. For Du, the logic doesn’t make sense.

“It’s hard for us to understand, part of it is about the coach pushing people in a way that’s high intensity and breathing hard,” Du said. “But there’s nothing stopping people from doing that if we put 12 people in there working out on their own.”

 

Guidelines don’t allow even a handful of participants to be led by a professional, even if it’s fewer numbers than a group without a trainer.

“As long as you have a group bigger than one you can’t have a coach present,” Du said.

These new rules are contradictory to the whole fitness model of some studios, ones that rely on the motivation of a trainer. Tricia McDonald owns Orangetheory Fitness in Airdrie.

“Typically we would have 24 people in here. But in this location we are capping it at 10 to 12 people per session,” McDonald said. “That means they are always physically distanced in the class. But there’s nobody coaching you into it anymore, so you have to essentially coach yourself.”

McDonald admits it is challenging but is grateful to be able to give clients the space to workout.

“To be able to pivot like this and stay open for them is so important to us right now,” McDonald said.

Orangetheory is preparing to launch a new platform called “Orangetheory Live” to adapt to the new guidelines.

“These will be coach inspired workouts you do in the safety of your own home,” McDonald said. “It’s not virtual, we are still connecting because the coach is there inspiring you, cheerleading you, correcting form and its much more than typical virtual workout.”

Video: Lethbridge fitness studio offers rent-a-bike program through COVID-19 restrictions

Source Article

Read more

How the Privatization of Medicine in India Is Accelerating Its COVID-19 Death Toll

Spiraling health care expenses in India have been pushing more than 55 million Indians into a state of abject poverty every year. COVID-19 has only worsened the trend for even more families—like Aghan Singh’s.

To ensure that his sick mother received the best treatment, Singh, a self-employed motor mechanic in the small town of Bilaspur, in Chhattisgarh, India, decided to take her to a popular private hospital nearby. She had been running a fever since July 7 and had also developed breathlessness by July 9. Singh rushed her to the hospital, and when they reached the emergency department around 8 p.m., her oxygen levels were dangerously low. The hospital ordered a battery of tests for COVID-19 and quickly admitted her to an intensive care unit to give her oxygen and medicine. In the first eight hours of his mother being admitted to the hospital, Singh deposited Rs 34,000 ($455) and then paid another Rs 1,96,000 ($2,627) over the next four days. To arrange money for his mother’s treatment, Singh had to sell off two and a half acres of land that he owned in his native village. Despite all his efforts, his mother’s condition worsened progressively, and she died on July 16. While still grieving the loss of his beloved mother, he was further stressed about how his family would survive the next month with most of his resources having been exhausted during his mother’s treatment.

Also in the state of Chhattisgarh, when 60-year-old Savani Bai from the village of Dhanokhar developed mild symptoms of COVID-19, she spoke to a doctor on the state helpline and was advised to go to the hospital. Since all the government hospital beds were occupied, she had to be admitted to the same private hospital in Bilaspur as Singh’s mother, where she was admitted to a general COVID ward. During her 10-day hospitalization, she was given acetaminophen and was kept under daily observation to ensure her condition was not worsening. For this basic treatment, she ended up spending Rs 85,000 ($1,137) and had to mortgage her one-acre farm to meet her hospital expenses.

“I took my mother to a private hospital near my home because it is cleaner and they admit patients swiftly throughout the day,” Singh said. Due to inadequate funding and monitoring of quality control in public hospitals, a large number of people in India are being forced to go to private hospitals for both outpatient, and to a lesser extent, inpatient care. It is a cruel joke that such a move to seek treatment in private hospitals by people is seen as a ‘choice’ rather than a compulsion.

India, which is the “second worst-hit country behind the United States,” has been fighting the COVID-19 pandemic with a fragile health system. The country saw one of the most draconian lockdowns anywhere in March, leading to a sense of panic and causing many private hospitals to simply shut up shop or turn away patients during the lockdown period. “I am 59 years old

Read more